Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Smith

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Nature Medicine|September 15, 2025
Primary care detection of Alzheimer's disease using a self-administered digital cognitive test and blood biomarkersPontus Tideman, Linda Karlsson, Olof Strandberg, et al.
Neurology|October 20, 2020
Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ loadAntoine Leuzy, Johan Lilja, Christopher J Buckley, et al.
EMBO Molecular Medicine|May 5, 2021
Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tauNiklas Mattsson-Carlgren, Shorena Janelidze, Randall J Bateman, et al.
Human Molecular Genetics|July 25, 2009
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretionRuben Smith, Karl Bacos, Valentina Fedele, et al.
Translational Psychiatry|January 27, 2021
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's diseaseMaurits Johansson, Erik Stomrud, Philip S Insel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 11, 2024
Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivoAlexa Pichet Binette, Angela Mammana, Laura Wisse, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairmentChrista J Maynard, Claudia Böttcher, Zaira Ortega, et al.
Preventing Chronic Disease|September 17, 2008
Reproductive health surveillance in the US-Mexico border region, 2003-2006: the Brownsville-Matamoros Sister City Project for Women's HealthJill A McDonald, Christopher H Johnson, Ruben Smith, et al.
Alzheimer'S Research & Therapy|March 22, 2026
Eligibility for amyloid targeting therapies among primary care patients with cognitive symptomsBeata Borgström Bolmsjö, Josef Barbosa Djärf, Danielle van Westen, et al.
Nature Communications|November 5, 2022
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's diseaseAlexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Nature Medicine|September 15, 2025
Primary care detection of Alzheimer's disease using a self-administered digital cognitive test and blood biomarkersPontus Tideman, Linda Karlsson, Olof Strandberg, et al.
Neurology|October 20, 2020
Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ loadAntoine Leuzy, Johan Lilja, Christopher J Buckley, et al.
EMBO Molecular Medicine|May 5, 2021
Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tauNiklas Mattsson-Carlgren, Shorena Janelidze, Randall J Bateman, et al.
Human Molecular Genetics|July 25, 2009
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretionRuben Smith, Karl Bacos, Valentina Fedele, et al.
Translational Psychiatry|January 27, 2021
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer's diseaseMaurits Johansson, Erik Stomrud, Philip S Insel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 11, 2024
Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivoAlexa Pichet Binette, Angela Mammana, Laura Wisse, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairmentChrista J Maynard, Claudia Böttcher, Zaira Ortega, et al.
Preventing Chronic Disease|September 17, 2008
Reproductive health surveillance in the US-Mexico border region, 2003-2006: the Brownsville-Matamoros Sister City Project for Women's HealthJill A McDonald, Christopher H Johnson, Ruben Smith, et al.
Alzheimer'S Research & Therapy|March 22, 2026
Eligibility for amyloid targeting therapies among primary care patients with cognitive symptomsBeata Borgström Bolmsjö, Josef Barbosa Djärf, Danielle van Westen, et al.
Nature Communications|November 5, 2022
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's diseaseAlexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Pageof 14